Jason Hoitt, Chief Commercial Officer at Provention Bio, Inc. (PRVB), bought 4,500 shares at $5.43 ($24K) on 2020-03-19, disclosed to the SEC on 2020-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| DOVA | SELL | 2019-10-02 | $67K | — | Filing → |
| DOVA | SELL | 2019-07-16 | $116K | — | Filing → |
| DOVA | SELL | 2019-07-02 | $33K | — | Filing → |